Table 1.
Number of samples | SARS-CoV-2 IgM | SARS-CoV-2 IgG | |||||||
---|---|---|---|---|---|---|---|---|---|
N | P | Clin Spe (%) | 95% CI | N | P | Clin Spe (%) | 95% CI | ||
Suspected group | 9 | 9 | 0 | 100.00 | (70.1%, 100.0%) | 9 | 0 | 100.00 | (70.1%, 100.0%) |
Control group | 101 | 100 | 1 | 99.01 | (94.6%, 99.8%) | 97 | 4 | 96.04 | (90.3%, 98.4%) |
N: negative; P: positive; Clin Sep: clinical specificity.